Findings

What do systematic reviews say?

6 questions · 6 findings · 2 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 33.3%Moderate 4 · 66.7%High 0 · 0%

Total mortality

Beta‐blockers showed no clear difference in total mortality compared with renin‐angiotensin system inhibitors (moderate certainty).

1 finding from 1 review

Beta‐blockers for hypertension 2017 · Cochrane Headline outcomes only
RR 1.1 [0.98, 1.24]
3 studies · 10828 participants
Moderate

Total mortality

Beta‐blockers showed no clear difference in total mortality compared with placebo (moderate certainty).

1 finding from 1 review

Beta‐blockers for hypertension 2017 · Cochrane Headline outcomes only
RR 0.99 [0.88, 1.11]
4 studies · 23613 participants
Moderate

Total mortality

Beta‐blockers showed no clear difference in total mortality compared with calcium‐channel blockers (moderate certainty).

1 finding from 1 review

Beta‐blockers for hypertension 2017 · Cochrane Headline outcomes only
RR 1.07 [1, 1.14]
4 studies · 44825 participants
Moderate

Total mortality

Beta‐blockers showed no clear difference in total mortality compared with diuretics (moderate certainty).

1 finding from 1 review

Beta‐blockers for hypertension 2017 · Cochrane Headline outcomes only
RR 1.04 [0.91, 1.19]
5 studies · 18241 participants
Moderate

All‐cause mortality (RR) · patients with chronic heart failure with preserved ejection fraction

Beta‐blockers showed no clear difference in all‐cause mortality (RR) compared with placebo or no treatment (low certainty).

1 finding from 1 review

Cardiovascular mortality · patients with chronic heart failure with preserved ejection fraction

Beta‐blockers may leads to lower cardiovascular mortality (RR) compared with placebo or no treatment (low certainty).

1 finding from 1 review